This science-backed method revolves around activating key arousal pathways with an FDA-approved peptide: PT-141 (bremelanotide), commonly known as the "Pink Shot." It addresses hypoactive sexual desire disorder (HSDD) by stimulating brain receptors involved in sexual motivation, leading to increased desire, better lubrication, heightened sensitivity, reduced pain during intercourse, and greater overall satisfactionwithout directly altering hormones.[1][2][3] Clinical trials show it can significantly improve sexual function scores in premenopausal women with HSDD, with up to 51% reporting enhanced desire compared to placebo groups, but its benefits extend to perimenopausal and postmenopausal women dealing with vaginal atrophy and low libido.[1] Weve long known that peptides can influence sexual health, but PT-141 stands out as the first FDA-approved injectable specifically for HSDD in women
This is likely because insulin resistance, insulin use, and long-standing metabolic disease can blunt weight-loss responses
Nutrition Guidance for Patients Taking GLP-1 Medications GLP-1 (Glucagon-like Peptide-1) medications are a class of drugs used primarily to treat type 2 diabetes and obesity
Key takeaways Weaning off semaglutide starts with talking to your healthcare provider
Ongoing medical guidance: You will receive continued medical guidance throughout your treatment to monitor your progress and manage any potential side effects
